CARGLUMIC ACID

CARGLUMIC ACID was reported 753 times

CARGLUMIC ACID is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYPERORNITHINAEMIA-HYPERAMMONAEMIA-HOMOCITRULLINURIA SYNDROME 1 1.0000
1 PERFORATION OF GREAT VESSELS 1 0.5000
2 NEONATAL HAEMOCHROMATOSIS 1 0.2500
3 OPHTHALMOLOGICAL EXAMINATION 2 0.1667
4 CARBAMOYL PHOSPHATE SYNTHETASE DEFICIENCY 2 0.1667
5 HYPERAMMONAEMIC CRISIS 12 0.1121
6 HYPERGLYCINAEMIA 2 0.0667
7 ELECTIVE PROCEDURE 1 0.0385
8 HYPERCATABOLISM 1 0.0263
9 ORNITHINE TRANSCARBAMOYLASE DEFICIENCY 1 0.0244
10 GASTROINTESTINAL TUBE REMOVAL 1 0.0222
11 NEURODEVELOPMENTAL DELAY 1 0.0217
12 AMMONIA INCREASED 92 0.0180
13 PO2 ABNORMAL 1 0.0175
14 GASTRIC PH INCREASED 2 0.0174
15 AMMONIA ABNORMAL 7 0.0174
16 SUDDEN INFANT DEATH SYNDROME 8 0.0163
17 ENDOVENOUS ABLATION 1 0.0152
18 NON-COMPACTION CARDIOMYOPATHY 1 0.0132
19 AMMONIA DECREASED 1 0.0128
20 CARNITINE DECREASED 1 0.0122
21 HYPERAMMONAEMIA 56 0.0112
22 AUTOIMMUNE ENCEPHALOPATHY 1 0.0099
23 INFANTILE SPITTING UP 5 0.0096
24 GAMMA-GLUTAMYLTRANSFERASE 1 0.0092
25 RENAL REPLACEMENT THERAPY 1 0.0078
26 PERIPHERAL ARTERY BYPASS 1 0.0075
27 RESPIRATORY SYNCYTIAL VIRUS BRONCHITIS 1 0.0074
28 FEEDING INTOLERANCE 3 0.0067
29 BLOOD KETONE BODY INCREASED 5 0.0064
30 DEVICE DEPENDENCE 1 0.0064
31 AMINO ACID LEVEL INCREASED 4 0.0054
32 LARYNGEAL STENOSIS 3 0.0052
33 HYPERAMMONAEMIC ENCEPHALOPATHY 9 0.0052
34 UPPER RESPIRATORY TRACT INFLAMMATION 6 0.0050
35 PULSE PRESSURE INCREASED 1 0.0048
36 METABOLIC DISORDER 28 0.0048
37 SYMPATHOMIMETIC EFFECT 1 0.0043
38 MENINGORRHAGIA 1 0.0040
39 GROSS MOTOR DELAY 1 0.0035
40 HEPATIC ARTERY THROMBOSIS 1 0.0034
41 DEVICE EMBOLISATION 1 0.0034
42 LIVER TRANSPLANT 12 0.0033
43 VAGAL NERVE STIMULATOR IMPLANTATION 1 0.0033
44 CONJUNCTIVITIS BACTERIAL 1 0.0029
45 DIET NONCOMPLIANCE 1 0.0027
46 STOMA SITE INFLAMMATION 2 0.0027
47 RHINOVIRUS INFECTION 10 0.0026
48 METAPNEUMOVIRUS INFECTION 2 0.0026
49 TRANSIENT TACHYPNOEA OF THE NEWBORN 1 0.0025
50 MENINGEAL DISORDER 1 0.0025
51 VIRAL PHARYNGITIS 1 0.0025
52 KETONURIA 2 0.0025
53 VIRAL RASH 1 0.0025
54 PERITONEAL DIALYSIS 2 0.0024
55 HERNIA PAIN 1 0.0022
56 EATING DISORDER SYMPTOM 1 0.0022
57 NEONATAL RESPIRATORY DISTRESS 2 0.0021
58 ACIDOSIS 16 0.0021
59 PCO2 DECREASED 2 0.0021
60 SPUTUM RETENTION 2 0.0020
61 TRACHEAL STENOSIS 1 0.0020
62 FAECAL VOLUME INCREASED 1 0.0019
63 URINE KETONE BODY PRESENT 3 0.0019
64 EXPULSION OF MEDICATION 1 0.0019
65 BLOOD GASES ABNORMAL 1 0.0019
66 MANUFACTURING PRODUCT SHIPPING ISSUE 1 0.0018
67 LIFE SUPPORT 1 0.0018
68 APNOEIC ATTACK 1 0.0018
69 MOTOR DEVELOPMENTAL DELAY 1 0.0017
70 ADENOVIRUS INFECTION 5 0.0017
71 BLOOD ELECTROLYTES ABNORMAL 2 0.0016
72 BLOOD BICARBONATE DECREASED 3 0.0016
73 GASTROENTERITIS NOROVIRUS 2 0.0015
74 DERMATITIS DIAPER 1 0.0014
75 NEONATAL ASPHYXIA 1 0.0014
76 IMMUNISATION REACTION 1 0.0014
77 NOROVIRUS INFECTION 2 0.0014
78 VASCULAR DEVICE INFECTION 6 0.0013
79 GASTROSTOMY 2 0.0013
80 CRITICAL ILLNESS 1 0.0013
81 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 1 0.0013
82 MYCOPLASMA INFECTION 1 0.0013
83 CROUP INFECTIOUS 1 0.0013
84 DIARRHOEA INFECTIOUS 1 0.0013
85 SEPSIS NEONATAL 1 0.0012
86 HAND-FOOT-AND-MOUTH DISEASE 1 0.0012
87 ENTEROVIRUS INFECTION 1 0.0012
88 BLOOD LACTIC ACID INCREASED 6 0.0011
89 HYPERLACTACIDAEMIA 3 0.0011
90 PRODUCT RECONSTITUTION QUALITY ISSUE 1 0.0011
91 CANDIDA SEPSIS 1 0.0011
92 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
93 CONSCIOUSNESS FLUCTUATING 1 0.0010
94 FEEDING DISORDER NEONATAL 1 0.0010
95 KETOSIS 1 0.0009
96 MOANING 1 0.0009
97 PO2 DECREASED 1 0.0009
98 RESPIRATORY TRACT INFECTION VIRAL 2 0.0009
99 LONG QT SYNDROME 2 0.0008
100 CARDIAC DEATH 1 0.0008
101 FEBRILE CONVULSION 1 0.0008
102 REBOUND EFFECT 9 0.0008
103 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
104 WHITE MATTER LESION 1 0.0008
105 NECROTISING COLITIS 1 0.0008
106 INCREASED BRONCHIAL SECRETION 2 0.0008
107 IATROGENIC INJURY 1 0.0008
108 GESTATIONAL HYPERTENSION 1 0.0008
109 OESOPHAGEAL HAEMORRHAGE 1 0.0008
110 AREFLEXIA 2 0.0007
111 STENOTROPHOMONAS INFECTION 1 0.0007
112 STREPTOCOCCAL INFECTION 4 0.0007
113 PERIPHERAL MOTOR NEUROPATHY 1 0.0007
114 TONIC CONVULSION 1 0.0007
115 INTELLECTUAL DISABILITY 1 0.0007
116 FUNGAL PERITONITIS 1 0.0007
117 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
118 DISEASE COMPLICATION 3 0.0007
119 BRAIN DEATH 2 0.0006
120 HYPOTONIA NEONATAL 1 0.0006
121 DEVICE OCCLUSION 9 0.0006
122 METABOLIC ALKALOSIS 1 0.0006
123 RESPIRATORY ALKALOSIS 1 0.0006
124 QUADRIPARESIS 1 0.0006
125 GASTRIC DILATATION 1 0.0006
126 PRODUCT SOLUBILITY ABNORMAL 3 0.0006
127 ENTERITIS INFECTIOUS 1 0.0006
128 BLOOD PH DECREASED 1 0.0006
129 ACUTE SINUSITIS 1 0.0006
130 TREATMENT DELAYED 1 0.0006
131 JUGULAR VEIN THROMBOSIS 1 0.0006
132 LIVER TRANSPLANT REJECTION 1 0.0006
133 PNEUMONIA KLEBSIELLA 1 0.0005
134 VIRAL INFECTION 18 0.0005
135 CARDIAC DYSFUNCTION 2 0.0005
136 STENOSIS 1 0.0005
137 PROTEIN TOTAL DECREASED 2 0.0005
138 BONE MARROW TRANSPLANT 1 0.0005
139 ARTERIAL THROMBOSIS 1 0.0005
140 EARLY SATIETY 1 0.0005
141 ABDOMINAL WALL HAEMATOMA 1 0.0005
142 CELL DEATH 1 0.0005
143 EXPOSURE VIA BREAST MILK 2 0.0005
144 DEVICE RELATED SEPSIS 1 0.0005
145 MICROCYTIC ANAEMIA 1 0.0005
146 INSULIN RESISTANCE 1 0.0005
147 CONGESTIVE CARDIOMYOPATHY 2 0.0005
148 GASTROENTERITIS 7 0.0005
149 FOETAL DISTRESS SYNDROME 1 0.0005
150 PRODUCT DISPENSING ISSUE 2 0.0005
151 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
152 HAEMOLYTIC ANAEMIA 4 0.0004
153 GASTROENTERITIS VIRAL 8 0.0004
154 BRAIN OPERATION 1 0.0004
155 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
156 VARICELLA 1 0.0004
157 STARING 1 0.0004
158 WRONG DOSE 1 0.0004
159 BREATH ODOUR 1 0.0004
160 METABOLIC ACIDOSIS 13 0.0004
161 STAPHYLOCOCCAL SEPSIS 2 0.0004
162 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
163 DEVICE INFUSION ISSUE 1 0.0004
164 HYPERPARATHYROIDISM SECONDARY 1 0.0004
165 SYSTEMIC CANDIDA 1 0.0004
166 BRAIN OEDEMA 5 0.0004
167 HERNIA REPAIR 1 0.0004
168 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
169 BRADYPNOEA 1 0.0004
170 BEHAVIOUR DISORDER 2 0.0004
171 CLONUS 1 0.0004
172 ENDOTRACHEAL INTUBATION 1 0.0004
173 HYPOPHAGIA 9 0.0004
174 ENTEROCOLITIS 2 0.0003
175 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
176 NECK INJURY 1 0.0003
177 PANCREATITIS 18 0.0003
178 BRAIN HERNIATION 1 0.0003
179 HYPERCAPNIA 1 0.0003
180 HOSPITALISATION 51 0.0003
181 EMERGENCY CARE 1 0.0003
182 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
183 RESPIRATORY RATE DECREASED 1 0.0003
184 FOREIGN BODY IN THROAT 1 0.0003
185 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
186 VOMITING 148 0.0003
187 PORTAL VEIN THROMBOSIS 1 0.0003
188 BACTERIAL SEPSIS 1 0.0003
189 PRODUCT PREPARATION ISSUE 2 0.0003
190 SUSPECTED COVID-19 1 0.0003
191 OTITIS MEDIA 1 0.0003
192 FEEDING DISORDER 6 0.0003
193 REGURGITATION 1 0.0003
194 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
195 EAR PRURITUS 1 0.0003
196 BRONCHIOLITIS 1 0.0003
197 RETCHING 6 0.0003
198 PHARYNGITIS STREPTOCOCCAL 3 0.0003
199 RENAL TRANSPLANT 1 0.0003
200 FAECES SOFT 2 0.0003
201 FOOD INTOLERANCE 1 0.0003
202 HEPATIC NECROSIS 1 0.0003
203 GASTRIC INFECTION 1 0.0003
204 BOWEL MOVEMENT IRREGULARITY 2 0.0003
205 BACTERAEMIA 3 0.0003
206 CEREBRAL ATROPHY 1 0.0003
207 PRODUCT PHYSICAL ISSUE 5 0.0002
208 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
209 SPINAL FUSION SURGERY 1 0.0002
210 DEMYELINATION 1 0.0002
211 HYPERURICAEMIA 1 0.0002
212 GASTROINTESTINAL PERFORATION 1 0.0002
213 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
214 MUSCLE FATIGUE 1 0.0002
215 HEPATIC CYTOLYSIS 3 0.0002
216 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
217 BLOOD MAGNESIUM DECREASED 2 0.0002
218 MULTI-ORGAN FAILURE 4 0.0002
219 LETHARGY 13 0.0002
220 ACUTE HEPATIC FAILURE 3 0.0002
221 ABDOMINAL HERNIA 1 0.0002
222 IRON DEFICIENCY ANAEMIA 2 0.0002
223 BACTERIAL INFECTION 4 0.0002
224 DIALYSIS 3 0.0002
225 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
226 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
227 PROTEIN URINE PRESENT 1 0.0002
228 HYPOTONIA 2 0.0002
229 HYPOTHERMIA 2 0.0002
230 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
231 PETIT MAL EPILEPSY 1 0.0002
232 RESPIRATORY FAILURE 14 0.0002
233 RESPIRATORY TRACT INFECTION 5 0.0002
234 SEIZURE 22 0.0002
235 PRODUCT RESIDUE PRESENT 1 0.0002
236 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
237 PRODUCT DOSE OMISSION 12 0.0002
238 ASPIRATION 2 0.0002
239 COAGULOPATHY 3 0.0002
240 INTRACRANIAL PRESSURE INCREASED 1 0.0002
241 ACUTE PULMONARY OEDEMA 1 0.0002
242 PERIORBITAL SWELLING 1 0.0002
243 CIRCULATORY COLLAPSE 3 0.0002
244 INTERNAL HAEMORRHAGE 2 0.0002
245 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
246 OFF LABEL USE 153 0.0002
247 HYPERVENTILATION 1 0.0002
248 HYPERTRIGLYCERIDAEMIA 1 0.0002
249 SEPSIS 19 0.0002
250 PROTHROMBIN TIME PROLONGED 1 0.0002
251 HEPATIC FAILURE 5 0.0002
252 HYPERGLYCAEMIA 6 0.0002
253 ENCEPHALOPATHY 4 0.0002
254 MUSCLE SPASTICITY 2 0.0002
255 OLIGURIA 1 0.0002
256 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
257 SCREAMING 1 0.0002
258 CHOLESTASIS 3 0.0002
259 PROCTALGIA 1 0.0002
260 LACTIC ACIDOSIS 5 0.0002
261 INFLUENZA 17 0.0002
262 APPETITE DISORDER 1 0.0002
263 EAR INFECTION 4 0.0002
264 CARDIAC FAILURE ACUTE 1 0.0001
265 PRODUCT TASTE ABNORMAL 2 0.0001
266 EYE MOVEMENT DISORDER 1 0.0001
267 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
268 RESPIRATION ABNORMAL 1 0.0001
269 HYPERTRANSAMINASAEMIA 1 0.0001
270 CARDIO-RESPIRATORY ARREST 6 0.0001
271 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
272 RETINAL HAEMORRHAGE 1 0.0001
273 PRODUCT SUPPLY ISSUE 1 0.0001
274 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
275 HYPERTHYROIDISM 2 0.0001
276 LIVER DISORDER 6 0.0001
277 CEREBRAL DISORDER 1 0.0001
278 TRANSAMINASES INCREASED 3 0.0001
279 RESPIRATORY DISORDER 4 0.0001
280 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
281 HAEMODYNAMIC INSTABILITY 1 0.0001
282 LIPASE INCREASED 1 0.0001
283 SHOCK 3 0.0001
284 FOOD ALLERGY 1 0.0001
285 CONCUSSION 1 0.0001
286 APNOEA 1 0.0001
287 PULMONARY HAEMORRHAGE 1 0.0001
288 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
289 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
290 BLOOD ALBUMIN DECREASED 1 0.0001
291 COMA 6 0.0001
292 MUSCLE DISORDER 1 0.0001
293 SHOCK HAEMORRHAGIC 1 0.0001
294 ABNORMAL FAECES 1 0.0001
295 STAPHYLOCOCCAL INFECTION 4 0.0001
296 CARDIAC ARREST 10 0.0001
297 MUSCLE INJURY 1 0.0001
298 HAEMODIALYSIS 1 0.0001
299 VITAMIN D DECREASED 1 0.0001
300 MYOPATHY 1 0.0001
301 PRODUCT COMMUNICATION ISSUE 1 0.0001
302 RESPIRATORY RATE INCREASED 1 0.0001
303 DEHYDRATION 15 0.0001
304 GASTROINTESTINAL INFECTION 1 0.0001
305 ANAL INCONTINENCE 1 0.0001
306 CRYING 4 0.0001
307 TREATMENT NONCOMPLIANCE 6 0.0001
308 BLOOD GLUCOSE ABNORMAL 2 0.0001
309 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
310 PRODUCT DISTRIBUTION ISSUE 1 0.0001
311 ACUTE RESPIRATORY FAILURE 2 0.0001
312 INFLAMMATORY BOWEL DISEASE 1 0.0001
313 ASCITES 3 0.0001
314 LABORATORY TEST ABNORMAL 3 0.0001
315 BODY TEMPERATURE DECREASED 1 0.0001
316 DISORIENTATION 4 0.0001
317 CARDIAC FAILURE 8 0.0001
318 PRODUCT ADMINISTRATION ERROR 2 0.0001
319 NASOPHARYNGITIS 18 0.0001
320 HYPERBILIRUBINAEMIA 1 0.0001
321 PRODUCT ODOUR ABNORMAL 1 0.0001
322 TRANSFUSION 1 0.0001
323 SUDDEN DEATH 1 0.0001
324 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
325 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
326 EATING DISORDER 2 0.0001
327 DECREASED ACTIVITY 1 0.0001
328 BACK INJURY 1 0.0001
329 SEPTIC SHOCK 4 0.0001
330 CONSTIPATION 20 0.0001
331 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
332 PYREXIA 31 0.0001
333 BLOOD CALCIUM DECREASED 1 0.0001
334 CONDITION AGGRAVATED 27 0.0001
335 STATUS EPILEPTICUS 1 0.0001
336 DELIRIUM 3 0.0001
337 ELECTROLYTE IMBALANCE 1 0.0001
338 RENAL DISORDER 4 0.0001
339 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
340 BLOOD IRON DECREASED 1 0.0001
341 ATAXIA 1 0.0001
342 ANAEMIA 16 0.0001
343 PRODUCTIVE COUGH 4 0.0001
344 MUSCLE RIGIDITY 1 0.0001
345 POLYNEUROPATHY 1 0.0001
346 INFECTION 12 0.0001
347 NO THERAPEUTIC RESPONSE 1 0.0001
348 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
349 GENERALISED OEDEMA 1 0.0001
350 ILEUS 1 0.0001
351 SECRETION DISCHARGE 1 0.0001
352 POISONING 1 0.0001
353 GASTROINTESTINAL DISORDER 7 0.0001
354 RHINORRHOEA 5 0.0001
355 GASTRITIS 2 0.0001
356 ADVERSE EVENT 7 0.0001
357 DYSMENORRHOEA 1 0.0001
358 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
359 TACHYPNOEA 1 0.0001
360 PALLOR 2 0.0001
361 PERIPHERAL COLDNESS 1 0.0001
362 DIARRHOEA 47 0.0001
363 RESPIRATORY ARREST 2 0.0001
364 DIVERTICULITIS 2 0.0001
365 HEPATOCELLULAR INJURY 1 0.0001
366 HYPERSOMNIA 2 0.0001
367 CARDIOGENIC SHOCK 1 0.0001
368 DECREASED APPETITE 16 0.0001
369 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
370 FLUID OVERLOAD 1 0.0001
371 COVID-19 12 0.0001
372 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
373 ILLNESS 7 0.0001
374 TACHYCARDIA 6 0.0001
375 PULMONARY OEDEMA 3 0.0001
376 BONE LOSS 1 0.0001
377 BLOOD POTASSIUM DECREASED 2 0.0001
378 EPILEPSY 2 0.0001
379 DEVICE RELATED INFECTION 1 0.0001
380 EJECTION FRACTION DECREASED 1 0.0001
381 THERAPY PARTIAL RESPONDER 1 0.0001
382 NERVOUS SYSTEM DISORDER 2 0.0001
383 PREMATURE DELIVERY 1 0.0001
384 LUNG DISORDER 3 0.0001
385 EYE DISORDER 2 0.0001
386 VENTRICULAR TACHYCARDIA 1 0.0001
387 PHOTOSENSITIVITY REACTION 1 0.0001
388 FUNGAL INFECTION 2 0.0001
389 URINARY RETENTION 2 0.0001
390 GAIT INABILITY 2 0.0001
391 CANDIDA INFECTION 1 0.0001
392 DISEASE PROGRESSION 7 0.0001
393 ANGER 2 0.0001
394 HYPERKALAEMIA 2 0.0001
395 HYPOXIA 2 0.0001
396 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
397 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
398 DEATH 48 0.0001
399 SOMNOLENCE 11 0.0001
400 ABDOMINAL DISCOMFORT 9 0.0001
401 FLATULENCE 3 0.0001
402 LOWER LIMB FRACTURE 1 0.0001
403 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
404 ERUCTATION 1 0.0001
405 DYSTONIA 1 0.0001
406 CHOKING 1 0.0001
407 DISABILITY 1 0.0001
408 UPPER LIMB FRACTURE 1 0.0001
409 PRESCRIBED UNDERDOSE 1 0.0001
410 IRRITABILITY 3 0.0000
411 HYPOTENSION 10 0.0000
412 PLEURAL EFFUSION 3 0.0000
413 PRODUCT PREPARATION ERROR 1 0.0000
414 PRODUCT DOSE OMISSION ISSUE 14 0.0000
415 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
416 PANCREATITIS ACUTE 1 0.0000
417 APPLICATION SITE PRURITUS 1 0.0000
418 MIGRAINE 4 0.0000
419 UNDERDOSE 3 0.0000
420 AGITATION 3 0.0000
421 DYSGEUSIA 3 0.0000
422 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
423 HAEMATEMESIS 1 0.0000
424 HAEMOGLOBIN DECREASED 4 0.0000
425 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
426 RENAL FAILURE 5 0.0000
427 FREQUENT BOWEL MOVEMENTS 1 0.0000
428 LIMB INJURY 1 0.0000
429 MOOD ALTERED 1 0.0000
430 INFLUENZA LIKE ILLNESS 3 0.0000
431 RESPIRATORY DISTRESS 1 0.0000
432 TREMOR 6 0.0000
433 RENAL IMPAIRMENT 3 0.0000
434 SKIN EXFOLIATION 3 0.0000
435 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
436 URINARY TRACT INFECTION 6 0.0000
437 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
438 DYSSTASIA 1 0.0000
439 ABDOMINAL PAIN UPPER 7 0.0000
440 PNEUMONIA 11 0.0000
441 PREMATURE BABY 1 0.0000
442 ILL-DEFINED DISORDER 2 0.0000
443 WEIGHT DECREASED 9 0.0000
444 EXPOSURE DURING PREGNANCY 2 0.0000
445 PRODUCT USE ISSUE 6 0.0000
446 HEAD INJURY 1 0.0000
447 MOVEMENT DISORDER 1 0.0000
448 DRUG INTOLERANCE 3 0.0000
449 CHOLELITHIASIS 1 0.0000
450 DYSPEPSIA 3 0.0000
451 ABDOMINAL PAIN 7 0.0000
452 SKIN DISORDER 1 0.0000
453 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
454 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
455 HEPATIC ENZYME INCREASED 2 0.0000
456 HAEMATURIA 1 0.0000
457 ABDOMINAL DISTENSION 3 0.0000
458 COUGH 8 0.0000
459 PLATELET COUNT DECREASED 3 0.0000
460 CEREBRAL HAEMORRHAGE 1 0.0000
461 BRONCHITIS 2 0.0000
462 COLITIS 1 0.0000
463 CHRONIC KIDNEY DISEASE 2 0.0000
464 DIABETES MELLITUS 2 0.0000
465 ACUTE KIDNEY INJURY 4 0.0000
466 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
467 ABNORMAL BEHAVIOUR 1 0.0000
468 CARDIAC FAILURE CONGESTIVE 2 0.0000
469 DEVICE BREAKAGE 1 0.0000
470 DYSKINESIA 1 0.0000
471 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
472 NEUTROPHIL COUNT DECREASED 1 0.0000
473 FATIGUE 19 0.0000
474 LUNG NEOPLASM MALIGNANT 1 0.0000
475 NAUSEA 19 0.0000
476 RHABDOMYOLYSIS 1 0.0000
477 OSTEOARTHRITIS 1 0.0000
478 HYPERHIDROSIS 3 0.0000
479 OVERDOSE 5 0.0000
480 PRODUCT STORAGE ERROR 2 0.0000
481 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
482 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
483 NEUTROPENIA 3 0.0000
484 HYPOKALAEMIA 1 0.0000
485 OROPHARYNGEAL PAIN 2 0.0000
486 CARDIAC DISORDER 2 0.0000
487 DYSPNOEA 12 0.0000
488 ARRHYTHMIA 1 0.0000
489 NEUROPATHY PERIPHERAL 2 0.0000
490 DISEASE RECURRENCE 1 0.0000
491 GAIT DISTURBANCE 4 0.0000
492 BLOOD GLUCOSE DECREASED 1 0.0000
493 HYPOGLYCAEMIA 1 0.0000
494 AGGRESSION 1 0.0000
495 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
496 FLUID RETENTION 1 0.0000
497 BRADYCARDIA 1 0.0000
498 ASTHENIA 7 0.0000
499 OEDEMA 1 0.0000
500 RASH 8 0.0000
501 DRUG INEFFECTIVE 24 0.0000
502 HAEMATOCHEZIA 1 0.0000
503 PANCYTOPENIA 1 0.0000
504 THROMBOCYTOPENIA 2 0.0000
505 OXYGEN SATURATION DECREASED 1 0.0000
506 HYPONATRAEMIA 1 0.0000
507 CEREBROVASCULAR ACCIDENT 3 0.0000
508 PRODUCT SUBSTITUTION ISSUE 1 0.0000
509 DYSPHONIA 1 0.0000
510 SURGERY 1 0.0000
511 NASAL CONGESTION 1 0.0000
512 FEELING ABNORMAL 4 0.0000
513 STOMATITIS 1 0.0000
514 MALAISE 7 0.0000
515 SWELLING FACE 1 0.0000
516 ALOPECIA 3 0.0000
517 HYPERTENSION 3 0.0000
518 THERAPY INTERRUPTED 1 0.0000
519 WEIGHT INCREASED 3 0.0000
520 HALLUCINATION 1 0.0000
521 UNEVALUABLE EVENT 1 0.0000
522 THROMBOSIS 1 0.0000
523 TREATMENT FAILURE 1 0.0000
524 BALANCE DISORDER 1 0.0000
525 INTENTIONAL PRODUCT MISUSE 1 0.0000
526 INSOMNIA 3 0.0000
527 NO ADVERSE EVENT 2 0.0000
528 HYPERSENSITIVITY 2 0.0000
529 BLOOD GLUCOSE INCREASED 2 0.0000
530 DYSPHAGIA 1 0.0000
531 CONTUSION 1 0.0000
532 HEART RATE INCREASED 1 0.0000
533 DIZZINESS 5 0.0000
534 ERYTHEMA 2 0.0000
535 HEADACHE 6 0.0000
536 HAEMORRHAGE 1 0.0000
537 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
538 MUSCULAR WEAKNESS 1 0.0000
539 PRURITUS 3 0.0000
540 DRY SKIN 1 0.0000
541 MEMORY IMPAIRMENT 1 0.0000
542 PAIN IN EXTREMITY 2 0.0000
543 CONFUSIONAL STATE 1 0.0000
544 DRUG DOSE OMISSION 1 0.0000
545 FALL 2 0.0000
546 URTICARIA 1 0.0000
547 TOXICITY TO VARIOUS AGENTS 1 0.0000
548 DEPRESSION 1 0.0000
549 INCORRECT DOSE ADMINISTERED 1 0.0000
550 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
551 ANXIETY 1 0.0000
552 PAIN 2 0.0000
553 ARTHRALGIA 1 0.0000